Sign in
GLSHQ Stock Price, Chart, Stats & News
Gelesis Holdings, Inc.
Save
Gelesis Holdings, Inc. (GLSHQ) does not currently pay a dividend.
7,334
Market cap
–
Current P/E
–
Forward P/E
GLSHQ chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Gelesis Holdings, Inc. operated as a commercial-stage biotherapeutics company, concentrating on the development of biomimetic solutions. Its core mission revolved around addressing the root causes of obesity and various chronic gastrointestinal ailments. Among its offerings was PLENITY, an orally administered, non-stimulant, and non-systemic product designed to assist with weight management.
Similar securities
Based on sector and market capitalization
Report issue